920 related articles for article (PubMed ID: 20809859)
1. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
[TBL] [Abstract][Full Text] [Related]
2. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
[TBL] [Abstract][Full Text] [Related]
3. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
Zucchelli G; Bernardi F; Montebugnoli L; De SM
J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
Sanz M; Tonetti MS; Zabalegui I; Sicilia A; Blanco J; Rebelo H; Rasperini G; Merli M; Cortellini P; Suvan JE
J Periodontol; 2004 May; 75(5):726-33. PubMed ID: 15212355
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
[TBL] [Abstract][Full Text] [Related]
6. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
[TBL] [Abstract][Full Text] [Related]
7. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
[TBL] [Abstract][Full Text] [Related]
8. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
[TBL] [Abstract][Full Text] [Related]
9. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
[TBL] [Abstract][Full Text] [Related]
10. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
Mengel R; Schreiber D; Flores-de-Jacoby L
J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
[TBL] [Abstract][Full Text] [Related]
11. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
[TBL] [Abstract][Full Text] [Related]
13. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
[TBL] [Abstract][Full Text] [Related]
14. Clinical performance of a regenerative strategy for intrabony defects: scientific evidence and clinical experience.
Cortellini P; Tonetti MS
J Periodontol; 2005 Mar; 76(3):341-50. PubMed ID: 15857066
[TBL] [Abstract][Full Text] [Related]
15. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.
Sculean A; Kiss A; Miliauskaite A; Schwarz F; Arweiler NB; Hannig M
J Clin Periodontol; 2008 Sep; 35(9):817-24. PubMed ID: 18647201
[TBL] [Abstract][Full Text] [Related]
16. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
[TBL] [Abstract][Full Text] [Related]
17. Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split-mouth study.
Sculean A; Schwarz F; Miliauskaite A; Kiss A; Arweiler N; Becker J; Brecx M
J Periodontol; 2006 Nov; 77(11):1879-86. PubMed ID: 17076614
[TBL] [Abstract][Full Text] [Related]
18. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
[TBL] [Abstract][Full Text] [Related]
19. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
Yilmaz S; Cakar G; Yildirim B; Sculean A
J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
[TBL] [Abstract][Full Text] [Related]
20. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.
Sculean A; Windisch P; Chiantella GC; Donos N; Brecx M; Reich E
J Clin Periodontol; 2001 May; 28(5):397-403. PubMed ID: 11350501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
